Compared to the historical benchmark, pelareorep-atezolizumab nearly tripled ORR Combination achieved encouraging median DOR ...

SAN FRANCISCO, CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Avinasi Labs, an AI-native longevity infrastructure company building the world’s first liquid foundation model for ageing ...

Volastra Therapeutics, a clinical-stage biotechnology company pioneering first-in-class therapies targeting chromosomal ...

Pills that work similarly to currently available injectable medications represent the next wave of metabolic disorder drugs, and Viking Therapeutics is pushing its drug candidate to the forefront with ...

The research has generated significant interest from firms in food & as consumers seek natural alternatives to GLP-1 drugs.

Through xCures’ IAS solution, Advokare expands patient access to structured health data that supports preparation, ...

Vizient® is proud to announce that the Vizient Clinical Data Base was recognized by Modern Healthcare as one of the Best in ...

What antibiotic should I use to treat this patient’s Klebsiella pneumoniae? It’s resistant to carbapenems, and there’s a ...

Penn Medicine links EHR with real-time care data to study clinician-patient interactions and improve clinical practice using multimodal datasets.

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much earlier, in how clinical trials are designed and who they include. As 2025 ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...